20.5 C
New York
Wednesday, June 3, 2026

Tag: crossover

newssourceFORcompanyinformationcontent1marketreleases

Studies show promising results for individuals with type 2 diabetes and young children with type 1 diabetes on MiniMed™ 780G system

Data supports the potential of future indication expansion for the MiniMed™ 780G system. LENNY trial results published in Lancet Diabetes & Endocrinology. GALWAY, Ireland and...

Ipsen receives positive CHMP opinion for Cabometyx® in previously treated advanced neuroendocrine tumors

PARIS, FRANCE, 20 June 2025 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for Cabometyx® (cabozantinib) for adult patients with unresectable or metastatic, well differentiated extra-pancreatic (epNET) and pancreatic (pNET) neuroendocrine tumors who have progressed following at least one prior systemic therapy other than somatostatin analogues. This recommendation is based on results from the CABINET Phase III trial presented at the European Society of Medical Oncology (ESMO) Congress 2024 and published in the New England Journal of Medicine.3,4 A final decision on the approval in the European Union is expected in the coming months.

Hyundai IONIQ 9 Named Favorite Plug-In EV By Midwest Automotive Media Association

Features standard NACS port and terrain modes for adventure-ready performanceConsensus pick of around 80 automotive media at MAMA's Spring RallyCHICAGO, June 13, 2025 /PRNewswire/...

Autos of Dallas Releases In-Depth Research on the Tesla Model Y and Highlights Expanding Inventory

Autos of Dallas, the go-to luxury used vehicle dealership near Dallas, TX, is proud to announce the launch of its latest research page. This...

Nutrishop Co-Founder & 75-Year-Old Father Team Up for 24th Race This Father’s Day

Father-daughter duo turns shared finish lines into a living testament that age is no barrier to wellness OLYMPIC VALLEY, Calif., June 10, 2025 /PRNewswire/ --...

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

CHENGDU, China, June 6, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating...

XOVR ETF Adds Anduril, Joining SpaceX to Offer Pre-IPO Access

XOVR ETF Adds Anduril to Crossover Fund. Joins SpaceX and Klarna as Private Equity Holdings in ETF that Holds 85%+ of Entrepreneur 30 Total Return Index

Chrysler Turns 100! Chrysler Brand Shares 1,500-plus 100th Birthday Group Photo Honoring Employees, Announces Century of Innovation Summer Celebration Events As It Looks to...

AUBURN HILLS, Mich., June 6, 2025 /PRNewswire/ -- ...

Supertrend and MA Cross Strategy — Signal Analysis and Trend Validation

OverviewThe Dynamic Supertrend MA Cross Quantitative Trading Strategy integrates the Supertrend indicator with Moving Average (MA) crossovers, optimized for 1-hour to 4-hour forex trading....

RSI-BB Crossover Strategy Seeks Momentum Confirmation — Optimized Exit Levels in Focus

OverviewThis strategy operates on decisive technical indicators, focusing on EMA crossovers, RSI thresholds, Bollinger Band breakouts, and volume analysis to determine long positions. It...

RSI-WMA Crossover Initiates Trend; EMA Filter Confirms Momentum

Technical OverviewThis approach is a quantitative trading system utilizing RSI-WMA crossovers and EMA trend filtering to generate signals. It captures crossover points of RSI...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCrossover

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers